Capsaicin and TRPV1: A Novel Therapeutic Approach to Mitigate Vascular Aging
Authors:
Open Access
- 1 January 2025
- journal article
- review article
- Published by Aging and Disease in Aging and disease
- Vol. 17 (1) , 256-274
Abstract
Vascular aging and its associated diseases represent a principal cause of mortality among the global elderly population, making the mitigation of vascular aging a significant aspiration for humanity. This article explores the intersection of nature and health, focusing on the role of the natural plant, pepper, and its principal bioactive compound, capsaicin, in combating vascular aging. By examining molecular and cellular mechanisms as well as phenotypic alterations in blood vessels, we offer a comprehensive review of the effects of capsaicin and its receptor, transient receptor potential vanilloid 1 (TRPV1), within vascular aging. We propose that capsaicin may serve as the medication with the potential to slow the progress of vascular aging and could constitute a new strategy to treat vascular aging related disease.Keywords
This publication has 184 references indexed in Scilit:
- Dihydrocapsaicin suppresses the STING‐mediated accumulation of ROS and NLRP3 inflammasome and alleviates apoptosis after ischemia–reperfusion injury of perforator skin flapPhytotherapy Research, 2024
- Transient receptor potential vanilloid 1 (TRPV1)‐independent actions of capsaicin on cellular excitability and ion transportMedicinal Research Reviews, 2023
- Controlled Activation of TRPV1 Channels on Microglia to Boost Their Autophagy for Clearance of Alpha‐Synuclein and Enhance Therapy of Parkinson's DiseaseAdvanced Materials, 2022
- The effect of red pepper/capsaicin on blood pressure and heart rate: A systematic review and meta‐analysis of clinical trialsPhytotherapy Research, 2021
- Phase I, Randomized, Double‐blind, Placebo‐controlled, Single‐dose, and Multiple‐dose Studies of Erenumab in Healthy Subjects and Patients With MigraineClinical Pharmacology & Therapeutics, 2017
- Medicinal Chemistry, Pharmacology, and Clinical Implications of TRPV1 Receptor AntagonistsMedicinal Research Reviews, 2016
- Potential therapeutic value of TRPV1 and TRPA1 in diabetes mellitus and obesitySeminars in Immunopathology, 2015
- Involvement of TRPV1 and TRPV4 channels in migration of rat pulmonary arterial smooth muscle cellsPflügers Archiv - European Journal of Physiology, 2012
- Functional Expression of Transient Receptor Potential Vanilloid-Related Channels in Chronically Hypoxic Human Pulmonary Arterial Smooth Muscle CellsThe Journal of Membrane Biology, 2008
- Trends in Prevalence, Awareness, Treatment, and Control of Hypertension in the United States, 1988-2000JAMA, 2003